Gillim-Ross Laura, Cara Andrea, Klotman Mary E
Mount Sinai School of Medicine, Division of Infectious Diseases, 1 Gustave L. Levy Place, Box 1090, New York, NY 10029, USA.
Laboratory of Virology, Istituto Superiore di Sanita, 00161 Roma, Italy.
J Gen Virol. 2005 Mar;86(Pt 3):765-771. doi: 10.1099/vir.0.80570-0.
Recently developed integrase inhibitors targeting the HIV-1 integrase (IN) protein block integration of HIV DNA in the target cell, preventing subsequent virus replication. In the absence of integration, viral DNA is shunted towards the formation of extrachromosomal DNA (E-DNA). Although HIV-1 E-DNA does not support productive replication, it is transcriptionally active and produces viral proteins. However, the significance of E-DNA in virus replication and pathogenesis is poorly understood. In this study, the functional activity of the HIV-1 Nef protein expressed in the absence of viral integration was analysed. Using both a recombinant HIV-1 IN defective virus and a diketo acid IN inhibitor, evidence was provided showing that Nef expressed from E-DNA downregulates CD4 surface expression on primary CD4(+) T lymphocytes. These results suggest that proteins expressed in the absence of integration may have potential clinical consequences, an issue that should be further explored with the introduction of IN inhibitors.
最近研发出的针对HIV-1整合酶(IN)蛋白的整合酶抑制剂可阻断HIV DNA在靶细胞中的整合,从而防止后续病毒复制。在没有整合的情况下,病毒DNA会转向形成染色体外DNA(E-DNA)。虽然HIV-1 E-DNA不支持有效复制,但它具有转录活性并能产生病毒蛋白。然而,E-DNA在病毒复制和发病机制中的意义仍知之甚少。在本研究中,分析了在没有病毒整合的情况下表达的HIV-1 Nef蛋白的功能活性。使用重组HIV-1 IN缺陷病毒和二酮酸IN抑制剂,提供了证据表明从E-DNA表达的Nef可下调原代CD4(+) T淋巴细胞表面CD4的表达。这些结果表明,在没有整合的情况下表达的蛋白质可能具有潜在的临床后果,随着整合酶抑制剂的引入,这一问题应进一步探讨。